{"id":"ambucetamide","rwe":[],"tags":[{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"phase_2","safety":{"commonSideEffects":[]},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"dibutamide","offLabel":[],"synonyms":["ambucetamide","dibutamide"],"timeline":[],"brandName":"Dibutamide","ecosystem":[],"mechanism":{"modality":"Small Molecule","explanation":"Imagine your body's cells are like locks, and proteins or receptors are like keys. Dibutamide is like a key that fits into a specific lock, allowing it to turn and unlock a particular cellular process. This process can help treat certain conditions, but the exact details of how it works are still unclear.","oneSentence":"Dibutamide works by binding to specific proteins or receptors in the body to produce its therapeutic effect.","technicalDetail":"Dibutamide's mechanism of action is likely to involve the modulation of ion channels or other cellular signaling pathways, but the specific molecular targets and downstream effects are not well-characterized."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/148","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=AMBUCETAMIDE","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T08:39:39.971163","biosimilars":[],"competitors":[],"genericName":"ambucetamide","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"131B408RZI","CHEBI":"CHEBI:135221","INN_ID":"627","UMLSCUI":"C1720172","ChEMBL_ID":"CHEMBL2104638","PUBCHEM_CID":"10616","SNOMEDCT_US":"420758002"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":3,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Dibutamide, also known as Ambucetamide, is a small molecule drug with unknown target and drug class. Its commercial status is unclear, and it is not FDA approved for any indications. As a small molecule, it is likely to work by interacting with specific biological molecules to produce its therapeutic effect. However, the exact mechanism of action and safety considerations are not well-documented. Further research is needed to fully understand this drug.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}